T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy

Authors

Brian B. Gowen, Utah State UniversityFollow
Donald F. Smee, Utah State UniversityFollow
Jeffery O. Hall, Utah State UniversityFollow
M. Wong
K. Jung, Utah State UniversityFollow
K. W. Bailey, Utah State UniversityFollow
J. R. Stevens
Y. Furuta
John D. Morrey, Utah State UniversityFollow

Document Type

Article

Journal/Book Title/Conference

PLoS ONE

Volume

3

Issue

11

Publisher

PLoS

Publication Date

2008

First Page

3725

Recommended Citation

Gowen BB, Smee DF, Hall JO, Wong M, Jung K, Bailey KW, Stevens JR, YF, and Morrey JD. T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model: T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to Ribavirin Therapy. PLoS ONE 3(11):e3725, 2008.